Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intraventricular Actilyse for spontaneous intraventricular hemorrhage
IRCT20200729048251N1Phase 3Completed
- Sponsor
- Guilan University of Medical Sciences
- Start
- Aug 2020
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised trial in Intraventricular hemorrhage (IVH) comparing Actilyse intraventricular injection with Placebo intraventricular injection (2 arms). Primary endpoints: Glasgow Coma Scale, Glasgow Outcome Scale and 6 more. Started Aug 2020; status: completed.
02
Drugs
tissue-plasminogen activator
03
Conditions
Intraventricular hemorrhage (IVH)
Beyond the preview
Go deeper on IRCT20200729048251N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200729048251N1.